Switching from EPA + DHA (Omega-3-acid Ethyl Esters) to High-Purity EPA (Icosapent Ethyl) in a Statin-Treated Patient with Persistent Dyslipidemia and High Cardiovascular Risk: A Case Study

Bibliographic Details
Main Author: James R. Crandell
Format: Article
Language:English
Published: SAGE Publishing 2016-07-01
Series:Clinical Medicine Insights: Cardiology
Online Access:http://www.la-press.com/switching-from-epa--dha-omega-3-acid-ethyl-esters-to-high-purity-epa-i-article-a5790

Similar Items